by teamneuro-kinesis | Jul 31, 2024 | News
FOR IMMEDIATE RELEASE NKC Announces Intent To Negotiate Technology Sale to BioSig Technologies DATELINE: July 31, 2024, Los Angeles, CA Neuro-Kinesis, Corp. (NKC), has announced it is negotiating with BioSig Technologies to sell its Huygens™ Cather and Proteus™...
by teamneuro-kinesis | Jan 26, 2024 | News
FOR IMMEDIATE RELEASE NKC Releases Q1/2024 Milestone Progress Update on the Huygens™/ Proteus™ Technology DATELINE: January 25, 2024, Los Angeles, CA Neuro-KInesis, Corp. (NKC), is providing the following to share the revised milestone timeline for Q1 and Q2,...
by teamneuro-kinesis | Dec 29, 2023 | News
FOR IMMEDIATE RELEASE NKC Releases 2023 End-of-Year Development Report on the Huygens™/ Proteus™ Technology DATELINE: December 28, 2023, Los Angeles, CA Neuro-KInesis, Corp. (NKC), is providing the following to share the 2023 third quarter updates on...
by teamneuro-kinesis | Nov 7, 2023 | News
FOR IMMEDIATE RELEASE NKC Releases 2023 Third Quarter Development Report on the Huygens™/ Proteus™ Technology DATELINE: November 07, 2023, Los Angeles, CA Neuro-KInesis, Corp. (NKC), is providing the following to share the 2023 third quarter updates on...
by teamneuro-kinesis | Dec 20, 2022 | News
FOR IMMEDIATE RELEASE NKC Releases Its End-Of-Year Development Report on the Huygens™/ Proteus™ Technology DATELINE: December 20, 2022, Los Angeles, CA Los Angeles, CA December 20, 2022 – The following is being provided to share the end-of-year updates on...
